Find open roles in Artificial Intelligence (AI), Machine Learning (ML), Natural Language Processing (NLP), Computer Vision (CV), Data Engineering, Data Analytics, Big Data, and Data Science in general, filtered by job title or popular skill, toolset and products used.

Aqemia announced on October 19 that it had raised €30 million in a Series A financing round co-led by Eurazeo and Bpifrance via its Large Venture fund, with the participation of Elaia, its historical investor. The deeptech company, which specializes in the discovery of drug candidates, will be able to use this financing to develop its exclusive drug discovery platform and its portfolio of therapeutic assets, as well as to recruit. Maximilien Levesque, its co-founder, after post-doctorates in statistical physics and fluid mechanics at ENS Paris and the universities of Cambridge and Oxford, worked as a CNRS researcher at ENS. He developed a statistical algorithm inspired by quantum mechanics that could have applications in drug discovery and focused the work of his group on drug design. He joined forces with Emmanuelle Martiano, a strategy consulting engineer at the Boston Consulting Group who has worked for pharmaceutical and BtoB software companies, and the two of them created Aqemia in June 2019.